Medevice

Dyameo develops single-use endoscopic probes that enable immediate detection of cancer cells. The company designs probes for in vivo cancer diagnosis, enabling differentiation of cancerous tissue during endoscopic examinations and supporting clinicians in early cancer detection.

Imactis is a company focused on computer-assisted interventional radiology, dedicated to enhancing the efficiency and safety of minimally invasive needle procedures such as biopsies, tumor ablations, vertebroplasties, infiltrations, and drainages. The company develops and markets innovative solutions that assist interventional radiologists by improving accuracy, facilitating complex procedures, and reducing both the duration of interventions and the need for multiple controls. Its technology simplifies multi-needle alignment, provides real-time treatment planning, and enables medical professionals to navigate around critical structures without angular limitations. Through these advancements, Imactis aims to improve patient outcomes and overall care in medical institutions.